Appian Customers Unlock AI's Full Potential by Embedding It in Business Processes
DENVER, April 30, 2025 /PRNewswire/ — Appian (Nasdaq: APPN) is giving customers…
April 30, 2025
Appian Embeds Agentic AI into Business Processes to Deliver Scalable, Governable Enterprise Value
Introducing new AI features and Data Fabric enhancements to deliver real-time insights…
April 30, 2025
137th Canton Fair Phase 2 Highlights Quality Home Life Through Innovation and Green Thinking
GUANGZHOU, China, April 30, 2025 /PRNewswire/ — Phase 2 of the 137th…
April 30, 2025
Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC, in Patients with Advanced Malignancies
SAN FRANCISCO and SUZHOU, China, April 30, 2025 /PRNewswire/ — Innovent Biologics,…
April 30, 2025
Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Hong Kong